Behavioral and neurobiological mechanisms of social cooperation
Human society operates on large-scale cooperation and shared norms of fairness. However, individual differences in cooperation and incentives to free-riding on others’ cooperation make large-scale cooperation fragile and can lead to reduced social-welfare. Deciphering the neural codes representing potential rewards/costs for self and others is crucial for understanding social decision-making and cooperation. I will first talk about how we integrate computational modeling with functional magnetic resonance imaging to investigate the neural representation of social value and the modulation by oxytocin, a nine-amino acid neuropeptide, in participants evaluating monetary allocations to self and other (self-other allocations). Then I will introduce our recent studies examining the neurobiological mechanisms underlying intergroup decision-making using hyper-scanning, and share with you how we alter intergroup decisions using psychological manipulations and pharmacological challenge. Finally, I will share with you our on-going project that reveals how individual cooperation spreads through human social networks. Our results help to better understand the neurocomputational mechanism underlying interpersonal and intergroup decision-making.
Stress and the Individual: Neurobiological Mechanisms Underlying Differential Susceptibilities and Adaptations
Dr. Carmen Sandi leads the laboratory of Behavioral Genetis in EPFL, Lausanne. Her lab investigates the impact and mechanism whereby stress and anxiety affect brain and behavior in an integrative program involvong studies in rodents and humans. She is the founder and co-president of Swiss Stress Network, co-director of Swiss National Centre of Competence in Research Synapsy. She is Chair of the ALBA Network, and pas-President of Cajal Advanced Neuroscience Training Program and the Federation of European Neuroscience Societies.
Schizophrenia and Substance Use Disorders: Cracking the Chicken-or-Egg Question
Although substance use disorders (SUDs) occur commonly in patients with schizophrenia and significantly worsen their clinical course, the neurobiological basis of SUDs in schizophrenia is not well understood. Therefore, there is a critical need to understand the mechanisms underlying SUDs in schizophrenia in order to identify potential targets for therapeutic intervention. Since drug use usually begins in adolescence, it is also important to understand the long-term effects of adolescent drug exposure on schizophrenia- and reward- related behaviors and circuitry. This talk will combine pharmacological, behavioral, electrophysiologic (local field potential recordings) and pre-clinical magnetic resonance imaging (resting-state functional connectivity and magnetic resonance spectroscopy) approaches to study these topics with an eye toward developing better treatment approaches.